Can Fite Biofarma (AMEX: CANF)
|Date||Analyst Firm||Analyst Name||Action||Rating||Action Price||Prior Price||Target|
You can purchase shares of Can Fite Biofarma (AMEX: CANF) through any online brokerage.
There are no as such competitors for Can Fite Biofarma.
The latest price target for Can Fite Biofarma (AMEX: CANF) was reported by Aegis Capital on Thursday, June 24, 2021. The analyst firm set a price target for 5.00 expecting CANF to rise to within 12 months (a possible 405.05% upside). 0 analyst firms have reported ratings in the last year.
The stock price for Can Fite Biofarma (AMEX: CANF) is $0.99 last updated June 29, 2022, 7:59 PM UTC.
There are no upcoming dividends for Can Fite Biofarma.
Can Fite Biofarma’s Q2 earnings are confirmed for Thursday, August 25, 2022.
There is no upcoming split for Can Fite Biofarma.
Can Fite Biofarma is in the Healthcare sector and Biotechnology industry. They are listed on the AMEX.